The effect of fetal bovine serum on polyene macrolide antibiotic cytotoxicity and antifungal activity. 1976

D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner

The relationships between fetal bovine serum (FBS) concentration and polyene macrolide antibiotic cytotoxicity to animal cells and to fungi were evaluated. The toxicity of amphotericin B (AB) and its derivative, amphotericin B methyl ester (AME), toward KB cells was found to be directly related to fetal bovine serum concentration. At higher FBS levels, increased concentrations of AB and AME were required to reduce 72-hr KB viable cell numbers of 50% of control values. Similarly, polyene macrolide antibiotic levels required to inhibit the growth of Saccharomyces cerevisiae to 50% of controls, and for obtaining minimum fungicidal concentrations (MFC), were greater when higher levels of FBS were used. In addition, AME was less toxic than AB toward KB cells grown in media containing 2, 5, 10, 15 or 20% FBS, whereas the antifungal activities of AB and AME were similar. AME was also capable of eliminating Candida albicans, Saccharomyces cerevisiae, Aspergillus niger or Fusarium moniliforme from KB cultures at antibiotic levels which exhibited less cell toxicity than did the concentrations of AB required for a similar response. These findings indicate that AME may be a potentially useful antifungal antibiotic for tissue culture systems.

UI MeSH Term Description Entries
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005670 Fusarium A mitosporic Hypocreales fungal genus, various species of which are important parasitic pathogens of plants and a variety of vertebrates. Teleomorphs include GIBBERELLA. Fusariums
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D001234 Aspergillus niger An imperfect fungus causing smut or black mold of several fruits and vegetables such as grapes, apricots, onions, and peanuts, and is a common contaminant of food. Aspergillus lacticoffeatus
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker

Related Publications

D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
February 1978, The Journal of antibiotics,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
January 1981, The Journal of antibiotics,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
January 2005, Acta biochimica Polonica,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
June 2004, Current medicinal chemistry,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
December 1978, Journal of cellular physiology,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
January 1984, Biochemical pharmacology,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
January 1996, Hindustan antibiotics bulletin,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
September 2013, Biotechnology letters,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
March 1974, Antibiotiki,
D P Bonner, and P B Fisher, and N I Goldstein, and W Mechlinski, and V Bryson, and C P Schaffner
May 2012, Gene,
Copied contents to your clipboard!